NEW YORK, May 1, 2018 /PRNewswire/ -- The Centers of Psychiatric Excellence (COPE) is pleased to present new research on the drug ketamine at The American Psychiatric Association's (APA) Annual Meeting in New York, NY, on Monday, May 7. The presentations will take place from 1:00 – 4:00 p.m. in room 1A14 on the first floor of The Javits Center.
COPE's session is called "Advances in Ketamine Research and Clinical Practice: Need for Evidence-Based Practice Guidelines" and will include the following presentations:
For more information about COPE's session on Ketamine, visit https://www.copepsychiatry.com/advances-in-ketamine-research-and-clinical-practice-need-for-evidence-based-practice-guidelines/
About COPE COPE (Centers of Psychiatric Excellence) is a management services organization that offers administrative and advisory support to independently operated psychiatric treatment clinics. COPE is proud to partner with highly specialized clinics around the country that service the most difficult to treat cases of depression, anxiety (specifically PTSD), and chronic pain.
COPE was founded by three internationally renowned psychiatrists at Duke University Medical Center: Prakash Masand, MD; Ashwin Patkar, MD; and Steven Szabo, MD. In their more than 60 years of clinical and academic experience, they saw a clear, unmet need to provide support and services to facilities that offer evidence-based, innovative treatment.You can visit https://www.copepsychiatry.com/
Media Contact Prakash Masand MD 919-619-5101 [email protected]
Advertisement
COPE's session is called "Advances in Ketamine Research and Clinical Practice: Need for Evidence-Based Practice Guidelines" and will include the following presentations:
Advertisement
Chair: Steven Szabo, M.D. (Duke University)
- Preclinical and Translational Neuroscience: A Brief History of Ketamine, presented by Gerard Sanacora, M.D., Ph.D. (Yale University)
- Updates on Subanesthetic Doses of Ketamine for Mood Spectrum Disorders, presented by Sanjay J. Mathew, M.D. (Baylor University)
- Updates on Subanesthetic Doses of Ketamine for Anxiety Spectrum Disorders, presented by James W. Murrough, M.D.(Mt Sinai,NY)
- Updates on Subanesthetic Doses of Ketamine for Management of Chronic Pain, presented by Ashwin A Patkar, M.D. ( Duke University)
- Development of Centers of Psychiatric Excellence and a Registry to Optimize Ketamine Administrations, presented by Prakash S. Masand, M.D. (Duke–National University of Singapore)
- Panel Discussion, led by Carlos A. Zarate, M.D. (National Institute of Mental Health)
For more information about COPE's session on Ketamine, visit https://www.copepsychiatry.com/advances-in-ketamine-research-and-clinical-practice-need-for-evidence-based-practice-guidelines/
About COPE COPE (Centers of Psychiatric Excellence) is a management services organization that offers administrative and advisory support to independently operated psychiatric treatment clinics. COPE is proud to partner with highly specialized clinics around the country that service the most difficult to treat cases of depression, anxiety (specifically PTSD), and chronic pain.
COPE was founded by three internationally renowned psychiatrists at Duke University Medical Center: Prakash Masand, MD; Ashwin Patkar, MD; and Steven Szabo, MD. In their more than 60 years of clinical and academic experience, they saw a clear, unmet need to provide support and services to facilities that offer evidence-based, innovative treatment.You can visit https://www.copepsychiatry.com/
Media Contact Prakash Masand MD 919-619-5101 [email protected]
View original content:http://www.prnewswire.com/news-releases/centers-of-psychiatric-excellence-cope-to-present-new-research-on-ketamine-at-the-american-psychiatric-associations-annual-meeting-in-new-york-city-on-may-7-300640257.html
SOURCE Centers of Psychiatric Excellence